bioRxiv ScienceSearch

Biology subjects

Harada, K.

Publications and source records attributed to Harada, K..

2 recordsLinked to original sources

Customizing material into embodied cap by sponge crab

Animal personality is considered to be developed through complex interactions of an individual with its surrounding environment. How can we quantify the personality of an individual? Quantifying intra- and inter-individual variability of behavior, or individual behavioral type, appears to be a prerequisite in the study of animal personality. We propose a statistical method from a predictive point of view to measure the appropriateness of our assumption of individual behavior in repeatedly measured behavioral data from several individuals. For a model case, we studied the sponge crab Lauridromia dehaani known to make and carry a cap from a natural sponge for camouflage. Because a cap is most likely to be rebuilt and replaced repeatedly, we hypothesized that each individual crab would grow a unique behavioral type and it would be observed under an experimentally controlled environmental condition. To test the hypothesis, we conducted behavioral experiments and employed a new Bayesian model-based comparison method to examine whether crabs have individual behavioral types in the cap making behavior. Crabs were given behavioral choices by using artificial sponges of three different sizes. We modeled the choice of sponges, size of the trimmed part of a cap, size of the cavity of a cap, and the latency to produce a cap, as random variables in 26 models, including hierarchical models specifying the behavioral types. In addition, we calculated the marginal-level widely applicable information criterion (mWAIC) values for hierarchical models to evaluate and compared them with the non-hierarchical models from the predictive point of view. As a result, the crabs of less than about 9 cm in size were found to make caps from the sponges. The body size explained the behavioral variables namely, choice, trimmed cap characteristics, and cavity size, but not latency. Furthermore, we captured the behavioral type as a probabilistic distribution structure of the behavioral data by comparing WAIC. Our statistical approach is not limited to behavioral data but is also applicable to physiological or morphological data when examining whether some group structure exists behind fluctuating empirical data.

animal behavior and cognition

Assessment of urinary pharmacodynamic profiles of faropenem against extended-spectrum β-lactamase-producing Escherichia coli with canine ex vivo modeling

Extended-spectrum {beta}-lactamase (ESBL)-producing bacteria are of great concern in companion animals with urinary tract infections (UTIs). Because of its high safety and stability in the presence of ESBLs, faropenem is assumed to be a candidate antimicrobial agent for canine UTIs with ESBL-producing bacteria. This study was performed to investigate the urinary pharmacokinetics and pharmacodynamics of faropenem administered at 5 mg/kg body weight in six healthy dogs using an ex vivo model. Six UTI pathogenic strains of ESBL-producing Escherichia coli (ESBL-EC) with the following faropenem minimum inhibitory concentrations (MICs) were used: 1 {micro}g/mL (n = 2), 2 {micro}g/mL (n = 2), 4 {micro}g/mL (n = 1), and 16 {micro}g/mL (n = 1). Urine samples were obtained every 4 h for the first 12 h after faropenem administration for measurement of the urine drug concentration and urinary bactericidal titers (UBTs). The urine concentration of faropenem peaked at 0 to 4 h after administration, with a mean maximum concentration of 584 g/mL, and markedly decreased at 8 to 12 h (23 g/mL). The median UBTs for all tested ESBL-EC strains were highest at 0 to 4 h and then significantly decreased at 8 to 12 h. These findings indicate that administration of faropenem more than once daily is recommended for the treatment of ESBL-EC-related UTIs in dogs. In addition, the median areas under the UBT-time curves (AUBTs) were significantly inversely correlated with the corresponding MICs for faropenem in the tested strains (P < 0.05). Notably, the median AUBTs were significantly higher in ESBL-EC strains with an MIC of 1 {micro}g/mL than in those with an MIC of [&ge;]4 {micro}g/mL (P < 0.05). The present study serves as the basis of clinical application of faropenem for ESBL-producing bacteria-related UTIs in dogs.

microbiology